Radiomedix Drug Patent Portfolio
Radiomedix owns 1 orange book drug protected by 4 US patents Given below is the list of Radiomedix's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12102696 | Radiolabeling and formulation for scale up of 64Cu-DOTATATE | 03 Sep, 2041 | Active |
| US10159759 | Pet tracer for imaging of neuroendocrine tumors | 23 Aug, 2032 | Active |
| US10383961 | PET tracer for imaging of neuroendocrine tumors | 23 Aug, 2032 | Active |
| US11160888 | PET tracer for imaging of neuroendocrine tumors | 23 Aug, 2032 | Active |
Latest Legal Activities on Radiomedix's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Radiomedix.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Requirement for information sent under 37 CFR 1.750 | 11 Jun, 2024 | US10383961 |
| Notice of Final Determination -Eligible | 11 Jun, 2024 | US10383961 |
|
FDA Final Eligibility Letter
Critical
| 30 Jan, 2024 | US10383961 |
| transaction for FDA Determination of Regulatory Review Period | 10 May, 2023 | US10383961 |
| transaction for FDA Determination of Regulatory Review Period | 18 Apr, 2023 | US10383961 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 13 Feb, 2023 | US10383961 |
| Second letter to regulating agency to determine regulatory review period | 17 Jun, 2022 | US10383961 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 15 Jun, 2022 | US10159759 |
| Letter from FDA or Dept of Agriculture re PTE application | 14 Jun, 2022 | US10383961 |
| Initial letter Re: PTE Application to regulating agency | 13 Apr, 2022 | US10383961 |
|
Recordation of Patent Grant Mailed
Critical
| 02 Nov, 2021 | US11160888 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 02 Nov, 2021 | US11160888 |
| Sequence Moved to Public Database | 02 Nov, 2021 | US11160888 |
|
Email Notification
Critical
| 14 Oct, 2021 | US11160888 |
|
Issue Notification Mailed
Critical
| 13 Oct, 2021 | US11160888 |
Radiomedix's Family Patents
Radiomedix Drug List
Given below is the complete list of Radiomedix's drugs and the patents protecting them.
1. Detectnet
Detectnet is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12102696 | Radiolabeling and formulation for scale up of 64Cu-DOTATATE |
03 Sep, 2041
(16 years from now)
| Active |
| US10159759 | Pet tracer for imaging of neuroendocrine tumors |
23 Aug, 2032
(7 years from now)
| Active |
| US10383961 | PET tracer for imaging of neuroendocrine tumors |
23 Aug, 2032
(7 years from now)
| Active |
| US11160888 | PET tracer for imaging of neuroendocrine tumors |
23 Aug, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Detectnet's drug page